Passions

Solving crossword puzzles

Reading “Harry Potter” books with my kids

Playing racket sports

Experience

HAYA Therapeutics Closes $65 Million Series A

May 8, 2025

Cooley advised HAYA Therapeutics, a biotechnology company pioneering precision RNA-guided regulatory genome-targeting therapeutics, on its $65 million Series A financing round. The round was led by Sofinnova Partners and Earlybird Venture Capital, with participation from Eli Lilly and Company, ATHOS, +ND Capital, Alexandria Venture Investments, and LifeLink Ventures, with additional support from existing investors Apollo Health Ventures, Longview Ventures (an affiliate of Broadview Ventures), 4see ventures, BERNINA Bioinvest and Schroders Capital.

Lawyers Danielle Gershowitz, Josh Seidenfeld, Amanda Gonzalez Burton, Kristine Kevorkova and Thomas Heiser led the Cooley team advising HAYA Therapeutics.

Related contacts

Danielle Gershowitz
Partner, New York
Josh Seidenfeld
Partner, Palo Alto
Amanda Gonzalez Burton
Associate, New York
Kristine Kevorkova
Associate, Santa Monica
Thomas Heiser
Associate, Palo Alto
Jessica Li
Associate, Palo Alto
Harriet Fraser
Associate, New York

Related Practices & Industries

Clay Announces $40 Million Preemptive Series B, $1.25 Billion Valuation

January 22, 2025

Cooley represented Clay, a company that helps go-to-market teams up-level their data enrichment and automate personalized outreach, in its $40 million preemptive Series B expansion funding at a $1.25 billion valuation.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Danielle Gershowitz
Partner, New York
Tommi McCarthy
Associate, New York
Pam Shu
Associate, New York
Sharon Connaughton
Special Counsel, Washington, DC
Calvin Lee
Associate, New York
Emily Lee
Associate, Palo Alto
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Yieldstreet Completes Acquisition of Cadre

January 23, 2024

Cooley advised Yieldstreet, a leading private market investing platform, on its acquisition of Cadre, an online real estate-focused investment platform that serves institutional and high net worth investors.

Read more

Related contacts

Sacha Ross
Partner, New York
David Silverman
Partner, New York
Nathan Baum
Special Counsel, New York
Danielle Gershowitz
Partner, New York
Sean Ruff
Partner, Washington, DC
Norris Kadet
Associate, New York
Stephanie Gentile
Partner, New York
David Walsh
Senior Counsel, Reston
Paula Fleckenstein
Associate, Reston
Patrick Flanagan
Partner, New York
Stacey Song
Partner, New York
Len Jacoby
Partner, New York
Eileen Marshall
Partner, Washington, DC
Joshua Mates
Partner, San Francisco
Zachariah A. Robert
Partner, Chicago
Tiana Demas
Partner
Todd Gluth
Partner, San Diego
Sharon Connaughton
Special Counsel, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
Stella Sarma
Partner, Brussels
Jeff Goldman
Special Counsel, Palo Alto
Kristin O'Hanlon
Special Counsel, San Francisco
Adam Fleisher
Partner, Washington, DC
Nathaniel Hearn Jr.
Associate, Chicago
Bomin Kim
Associate, New York
Allison Kutner
Associate, New York
Arthi Naini
Associate, New York
Steven A. Zuckerman
Associate, New York
Julie Paulino Montejo
Associate, New York
Margaret Barreto
Associate, San Francisco
Edward (Teddy) Nimetz
Associate, New York
Calvin Lee
Associate, New York
Kristin R. Marshall
Associate, Washington, DC
Patricia Myers
Paralegal Specialist, Colorado
Loraine Torres
Paralegal Specialist, Colorado
Margie Murphy
Paralegal Specialist, New York

Related Practices & Industries

Runway Closes $50 Million Series C Financing

December 9, 2022

Cooley represented Runway, a developer of design tools made to bring the benefits of artificial intelligence to creative projects, on its $50 million Series C financing led by Felicis. Partner Sacha Ross led the Cooley team.

Related contacts

Sacha Ross
Partner, New York
Roy Moran
Partner, New York
Danielle Gershowitz
Partner, New York
Jayne M. Munger
Associate, New York
Katharina Schwarz
Associate, New York

Related Practices & Industries

CinCor Pharma – $212 Million IPO

January 7, 2022

Cooley advised CinCor Pharma on its upsized $212 million initial public offering of 13,290,813 shares of common stock, which included a partial exercise of the underwriter’s option to purchase additional shares of common stock. CinCor, whose shares now trade on the Nasdaq Global Market under the symbol CINC, is a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. CinCor’s IPO was one of the first IPOs of 2022. Partners Ryan Sansom, Div Gupta and Courtney Thorne led the Cooley team.

Related contacts

Ryan Sansom
Partner, Boston
Div Gupta
Partner, New York
Courtney Thorne
Partner, London
Barry Kuang
Associate, Boston
Alexander Fullman
Associate, New York
Cathy Rude
Paralegal Specialist, Boston
Danielle Gershowitz
Partner, New York

Related Practices & Industries

View more

Admissions and credentials

New York

Pennsylvania